HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P D Nathan Selected Research

Antineoplastic Agents (Antineoplastics)

7/2011Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P D Nathan Research Topics

Disease

5Melanoma (Melanoma, Malignant)
12/2019 - 07/2009
2Neoplasms (Cancer)
01/2018 - 04/2010
1Neoplasm Metastasis (Metastasis)
01/2018
1Disease Progression
05/2014
1Kidney Neoplasms (Kidney Cancer)
09/2013
1Ovarian Neoplasms (Ovarian Cancer)
09/2005
1Renal Cell Carcinoma (Grawitz Tumor)
03/2002

Drug/Important Bio-Agent (IBA)

2Bevacizumab (Avastin)FDA Link
12/2019 - 01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1Monoclonal AntibodiesIBA
01/2018
1AZD 6244IBA
05/2014
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2014
1Docetaxel (Taxotere)FDA Link
05/2014
1Tyrosine Kinase InhibitorsIBA
09/2013
1Biomarkers (Surrogate Marker)IBA
09/2013
1Antineoplastic Agents (Antineoplastics)IBA
07/2011
1Dacarbazine (DIC)FDA LinkGeneric
07/2011
1Sorafenib (BAY 43-9006)FDA Link
07/2011
1Phosphates (Orthophosphate)IBA
04/2010
1combretastatinIBA
04/2010
1Carboplatin (JM8)FDA LinkGeneric
04/2010
1Paclitaxel (Taxol)FDA LinkGeneric
04/2010
1Phosphotransferases (Kinase)IBA
07/2009
1InterferonsIBA
03/2002
1Thalidomide (Thalomid)FDA Link
03/2002

Therapy/Procedure

3Therapeutics
07/2011 - 07/2009
1Drug Therapy (Chemotherapy)
09/2005